NCT06796907 - A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors | Biotech Hunter

Enrollment

392

Participants

Timeline

Start Date

March 4, 2025

Primary Completion Date

December 17, 2027

Study Completion Date

April 5, 2028

Conditions

Tumours, Gynecological

Interventions

DRUG

GSK5733584

GSK5733584 will be administered intravenously (IV).

DRUG

Dostarlimab

Dostarlimab will be administered IV.

DRUG

Bevacizumab

Bevacizumab will be administered IV.

DRUG

Anticancer therapy 3

Anticancer therapy 3 will be administered IV.

DRUG

Anticancer therapy 4

Anticancer therapy 4 will be administered IV.

Trial Locations (56)

1200

RECRUITING

GSK Investigational Site, Brussels

2100

RECRUITING

GSK Investigational Site, Copenhagen

2170

RECRUITING

GSK Investigational Site, Liverpool

2500

RECRUITING

GSK Investigational Site, Wollongong

3000

RECRUITING

GSK Investigational Site, Leuven

4000

RECRUITING

GSK Investigational Site, Liège

6170

RECRUITING

GSK Investigational Site, Ankara

9000

RECRUITING

GSK Investigational Site, Ghent

11528

RECRUITING

GSK Investigational Site, Athens

12462

RECRUITING

GSK Investigational Site, Athens

17164

RECRUITING

GSK Investigational Site, Stockholm

28033

RECRUITING

GSK Investigational Site, Madrid

28041

RECRUITING

GSK Investigational Site, Madrid

28050

RECRUITING

GSK Investigational Site, Madrid

29010

RECRUITING

GSK Investigational Site, Málaga

33520

RECRUITING

GSK Investigational Site, Tampere

34010

RECRUITING

GSK Investigational Site, Istanbul

34298

RECRUITING

GSK Investigational Site, Montpellier

46009

RECRUITING

GSK Investigational Site, Valencia

50009

RECRUITING

GSK Investigational Site, Zaragoza

55236

RECRUITING

GSK Investigational Site, Thessaloniki

69495

RECRUITING

GSK Investigational Site, Pierre-Bénite

81377

RECRUITING

GSK Investigational Site, München

94805

RECRUITING

GSK Investigational Site, Villejuif

C1280AEB

RECRUITING

GSK Investigational Site, Buenos Aires

C1187

RECRUITING

GSK Investigational Site, CABA

R8500ACE

RECRUITING

GSK Investigational Site, Viedma

59075-740

RECRUITING

GSK Investigational Site, Natal

90020-090

RECRUITING

GSK Investigational Site, Porto Alegre

01246-000

RECRUITING

GSK Investigational Site, São Paulo

29043-260

RECRUITING

GSK Investigational Site, Vitória

M5G 2M9

RECRUITING

GSK Investigational Site, Toronto

H2X 0A9

RECRUITING

GSK Investigational Site, Montreal

H4A 3J1

RECRUITING

GSK Investigational Site, Montreal

00029

RECRUITING

GSK Investigational Site, Helsinki

570 01

RECRUITING

GSK Investigational Site, Pylaia Thessaloniki

277-8577

RECRUITING

GSK Investigational Site, Chiba

811-1395

RECRUITING

GSK Investigational Site, Fukuoka

104-0045

RECRUITING

GSK Investigational Site, Tokyo

135-8550

RECRUITING

GSK Investigational Site, Tokyo

1066 CX

RECRUITING

GSK Investigational Site, Amsterdam

3015 GD

RECRUITING

GSK Investigational Site, Rotterdam

0379

RECRUITING

GSK Investigational Site, Oslo

Unknown

RECRUITING

GSK Investigational Site, Panama City

RECRUITING

GSK Investigational Site, Panama City

RECRUITING

GSK Investigational Site, Punta Pacifica Panama City Panama

05-410

RECRUITING

GSK Investigational Site, Józefów

01-748

RECRUITING

GSK Investigational Site, Warsaw

05505

RECRUITING

GSK Investigational Site, Seoul

120-752

RECRUITING

GSK Investigational Site, Seoul

08023

RECRUITING

GSK Investigational Site, Barcelona

08035

RECRUITING

GSK Investigational Site, Barcelona

08036

RECRUITING

GSK Investigational Site, Barcelona

06590

RECRUITING

GSK Investigational Site, Ankara

G12 0YN

RECRUITING

GSK Investigational Site, Glasgow

NW1 2BU

RECRUITING

GSK Investigational Site, London